Diaclone is Part of Medix Biochemica

Medix Biochemica acquired Diaclone in July 2021, a well establish provider of raw material monoclonal antibodies and ELISA / ELISpot immunoassays in the areas of inflammation, oncology and immunology to a broad range of customers in Life Science, IVD, Pharma and Veterinary companies.

This acquisition expands Medix Biochemica’s portfolio, bringing complementary scientific and technological capabilities and strengthening the company’s local presence in Western Europe.

Medix Biochemica is a market-leading in vitro diagnostics raw material supplier with Finnish roots and global branches. We produce and supply high-quality antibodies, antigens and other critical IVD raw materials to enable our IVD customers to manufacture diagnostic tests and supporting materials all around the world.